Comparison of stable human Treg and Th clones by transcriptional profiling

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 869-882

  Stockis, Julie ^a   Fink, Wolfram ^a   Francois, Violine ^a,b   Connerotte, Thierry ^a   de Smet, Charles ^a   Knoops, Laurent ^a,c   van der Bruggen, Pierre ^a,b   Boon, Thierry ^a,b   Coulie, Pierre G ^a   Lucas, Sophie ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Human T cell clones; TGF ; Treg

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; SMAD2 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; SMAD2 PROTEIN, HUMAN;

ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEMETHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HELPER CELL; HEMOCHROMATOSIS; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; INTRON; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; MALE; MELANOMA; MIXED LYMPHOCYTE CULTURE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; CELL CLONE; COMPARATIVE STUDY; DNA METHYLATION; GENETICS; IMMUNOLOGY; METABOLISM; SKIN TUMOR;

CLONE CELLS; DNA METHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MELANOMA; SKIN NEOPLASMS; SMAD2 PROTEIN; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 64049118001     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838807     Document Type: Article

References (51)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005. 6: 345-352.
2. + T cells: A common basis between tumor immunity and autoimmunity. J. Immunol. 1999. 163: 5211-5218.
3. Zheng, Y. and Rudensky, A. Y., Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007. 8: 457-462.
4. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
5. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
6. + regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
7. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C. and Bowcock, A. M., JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000. 106: R75-R81.
8. Gavin, M. A., Torgerson, T. R., Houston, E., DeRoos, P., Ho, W. Y., Stray-Pedersen, A., Ocheltree, E. L. et al., Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 2006. 103: 6659-6664.
9. - T cells. J. Clin. Invest. 2003. 112: 1437-1443.
10. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 2983-2990.
11. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J., Thiel, A. et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007. 37: 2378-2389.
12. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K. et al., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007. 5: E38.
13. Boon, T., Coulie, P. G., Van den Eynde, B. and van der Bruggen, P., Human T cell responses against melanoma. Annu. Rev. Immunol. 2006. 24: 175-208.
14. + T regulatory cells in humans. Hum. Immunol. 2005. 66: 13-20.
15. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. and Levings, M. K., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345-354.
16. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
17. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A., Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 2002. 3: 33-41.
18. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A. and Rudensky, A. Y., Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007. 445: 771-775.
19. Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D. and Benoist, C., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007. 27: 786-800.
20. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329-341.
21. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006. 18: 1197-1209.
22. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 2004. 199: 1479-1489.
23. Lin,W., Haribhai, D., Relland, L. M., Truong, N., Carlson, M. R., Williams, C. B. and Chatila, T. A., Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007. 8: 359-368.
24. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004. 172: 5149-5153.
25. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A. et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005. 102: 15545-15550.
26. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P. et al., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003. 34: 267-273.
27. ten Dijke, P. and Arthur, H. M., Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell. Biol. 2007. 8: 857-869.
28. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 1335-1346.
29. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskuyoff, D. J. and Rifkin, D. B., An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994. 216: 276-284.
30. + T regulatory cells. J. Immunol. 2006. 177: 6091-6097.
31. + regulatory T cell activity in both humans and mice. J. Immunol. 2004. 172: 834-842.
32. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 2006. 177: 2331-2339.
33. Bird, A., DNA methylation patterns and epigenetic memory. Genes Dev. 2002. 16: 6-21.
34. Kim, H. P. and Leonard, W. J., CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: A role for DNA methylation. J. Exp. Med. 2007. 204: 1543-1551.
35. Mantel, P. Y., Ouaked, N., Ruckert, B., Karagiannidis, C., Welz, R., Blaser, K. and Schmidt-Weber, C. B., Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2006. 176: 3593-3602.
36. + regulatory T cells. J. Exp. Med. 2005. 201: 1061-1067.
37. Piccirillo, C. A., Letterio, J. J., Thornton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H. and Shevach, E. M., CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 2002. 196: 237-246.
38. + T cells. J. Exp. Med. 1996. 183: 2669-2674.
39. Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A. and Powrie, F., T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 2005. 201: 737-746.
40. Collison, L.W.,Workman, C. J., Kuo, T. T., Boyd, K.,Wang, Y., Vignali, K. M., Cross, R. et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007. 450: 566-569.
41. + regulatory T cells do not constitutively express IL-35. J. Immunol. 2008. 181: 6898-6905.
42. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
43. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., Heib, V. et al., Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 2007. 204: 1303-1310.
44. + regulatory T cell function. Eur. J. Immunol. 2004. 34: 2480-2488.
45. van Baren, N., Bonnet, M. C., Dréno, B., Khammari, A., Dorval, T., Piperno-Neumann, S., Liénard, D. et al., Tumoral and immunological responses following vaccination of melanoma patients with an ALVAC virus encoding Mage antigens recognized by T cells. J. Clin. Oncol. 2005. 23: 9008-9021.
46. Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F. et al., High frequency of anti-tumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J. Exp. Med. 2005. 201: 241-248.
47. Godelaine, D., Carrasco, J., Lucas, S., Karanikas, V., Schuler-Thurner, B., Coulie, P. G., Schuler, G. et al., Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide. J. Immunol. 2003. 171: 4893-4897.
48. Coulie, P. G., Karanikas, V., Colau, D., Lurquin, C., Landry, C., Marchand, M., Dorval, T. et al., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc. Natl. Acad. Sci. USA 2001. 98: 10290-10295.
49. Karanikas, V., Lurquin, C., Colau, D., van Baren, N., De Smet, C., Lethé, B., Connerotte, T. et al., Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus. J. Immunol. 2003. 171: 4898-4904.
50. Ma, W., Germeau, C., Vigneron, N., Maernoudt, A.-S., Morel, S., Boon, T., Coulie, P. G. and Van den Eynde, B., Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int. J. Cancer 2004. 109: 698-702.
51. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F. and Boon, T., The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 1996. 93: 7149-7153.